Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Fiona Powrie was one of four researchers from the University of Oxford recognised for their outstanding contributions to immunology with Honorary Lifetime Membership of the British Society for Immunology.

Fiona Powrie receives an Honorary Lifetime Membership of the British Society for Immunology at the BSI Congress
Fiona Powrie receives an Honorary Lifetime Membership of the British Society for Immunology at the BSI Congress

Fiona Powrie, Director of the Kennedy Institute was awarded honorary membership in recognition of her contributions to the field of immunology, including her seminal work on regulatory T cells and pioneering gut immunology research. The awards were announced at the recent British Society for Immunology Congress held in Edinburgh.

Professors Dame Sarah Gilbert, Teresa Lambe, and Sir Andrew Pollard received the awards for developing the ChAdOx1 nCoV-19 coronavirus vaccine, and all four have inspired scores of new immunologists in the field.

Fiona said: 'As an immunologist it is particularly special to be recognised by my colleagues with Lifetime Membership of the British Society for Immunology. I have been a member of the BSI since I started my training and benefited then from the science and networking opportunities as do members of my lab today.'

Professors Gilbert, Lambe and Pollard also accepted the Global Impact and Innovation Award in recognition of all those involved in the design and development of the ChAdOx1 nCoV-19, including the scientists, support staff and clinical trial volunteers.

Professor Teresa Lambe OBE, Head of Vaccine Immunology at the Oxford Vaccine Group, said: 'It is an honour to be recognised with this award from my fellow immunologists, but in particular I was humbled to accept the award on behalf of the teams who have worked across the ChAdOx1 nCoV-19 vaccine development here at Oxford, whose efforts have been integral to seeing this vaccine developed in record time, with over 2 billion doses now released worldwide.'

 

Similar stories

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Dr Alex Clarke wins Emerging Leaders Prize for lupus research

Alex is one of three exceptional lupus researchers that have been announced as winners of the Medical Research Foundation’s sixth Emerging Leaders Prize.

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

The Kennedy Institute scoops sustainability award

A new roof extension was awarded the 2021 Green Award for Sustainability by the Oxford Preservation Trust alongside a Certificate in the New Building category.